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Abstract
We present a method for handling dose constraints as part of a convex programming
framework for inverse treatment planning. Our method uniformly handles mean dose,
maximum dose, minimum dose, and dose-volume (i.e., percentile) constraints as part of
a convex formulation. Since dose-volume constraints are non-convex, we replace them
with a convex restriction. This restriction is, by definition, conservative; to mitigate
its impact on the clinical objectives, we develop a two-pass planning algorithm that
allows each dose-volume constraint to be met exactly on a second pass by the solver if its
corresponding restriction is feasible on the first pass. In another variant, we add slack
variables to each dose constraint to prevent the problem from becoming infeasible when
the user specifies an incompatible set of constraints or when the constraints are made
infeasible by our restriction. Finally, we introduce ConRad, a Python-embedded open-
source software package for convex radiation treatment planning. ConRad implements
the methods described above and allows users to construct and plan cases through a
simple interface.
1 Introduction
External beam radiation therapy is the treatment of diseased tissue with beams of ionizing
radiation delivered from a source outside the patient. When radiation passes through the
patient, it damages both healthy and diseased tissue. A treatment plan must be carefully
designed to minimize harm to healthy organs, while delivering enough dose to ablate the tar-
geted tissue. With recent hardware advances, delivered beams can be positioned and shaped
with growing sophistication, and clinicians rely increasingly on optimization techniques to
guide their treatment decisions. In this paper, we focus on one part of the treatment planning
process: the selection of an optimal intensity profile for every radiation beam.
In [SFOM99], the authors provide a comprehensive survey of several problem formula-
tions for treatment planning, including linear [RLMB91] [Ho¨l03] and quadratic programming
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models [JBBS90, XC96, XHS+98]. Generally, linear models minimize the weighted sum of
doses or the maximum deviation from a prescribed dose, while quadratic models minimize the
weighted sum of squared difference between actual and prescribed dose. These formulations
incorporate linear bounds on the dose to each structure. Solutions can be rapidly found using
various interior point methods, such as primal-dual [AGRD10], projected gradient [AMS13],
and interior point constraint generation [OGTA11].
To address conflicting clinical goals, researchers have proposed models with multiple
objectives and constraints. By varying the weight on each objective, one can produce a set
of solutions on the Pareto frontier [HK02] [HCB06a]. A large number of treatment evaluation
criteria can be transformed into convex criteria within this framework [RDL04]. Although
multi-objective optimization offers flexibility, calculating thousands of points on the Pareto
frontier proves computationally inefficient in practice, and expert judgment is still required
to select a clinically acceptable plan from the set of mathematically optimal plans.
All the methods discussed so far hinge on a convex problem formulation. However, many
clinically relevant constraints are non-convex. One such type is the dose-volume constraint,
which bounds the dose delivered to a given percentage of a patient’s anatomy [ZLL+14].
A review of some models for handling this class of constraints is given in [EGHS08]. The
simplest approach is to add a nonlinear, volume-sensitive penalty to the objective function
[CLI+98] [SC98]. Then, a local search algorithm, such as the conjugate gradient method
[XC96] [XHS+98] [SORM00] or simulated annealing [Web89] [Web92] [MM93], is used to
solve the optimization problem. Unfortunately, since this formulation is non-convex, these
algorithms often produce a local minimum, resulting in a sub-optimal treatment plan [Dea97]
[WM02]. Another method is to directly model the dose-volume constraint with a set of
binary decision variables. Each variable indicates whether a voxel should be included in the
fraction of a structure’s volume that must fulfill the dose bound [LBU+90] [LFC00] [LFC03].
Given the dimensions of patient data, this results in a large-scale mixed-integer programming
problem, which is prohibitively expensive to compute for most clinical cases.
A more promising approach is to replace each dose-volume constraint with a convex
approximation. This allows users to take advantage of large-scale convex optimization al-
gorithms to quickly generate treatment plans. For instance, [HCB06b] substitutes a ramp
function for the indicator that a particular voxel violates its desired dose-volume threshold,
then penalizes the total number of voxel violations in the objective. Other researchers have
employed the conditional value-at-risk (CVaR), a metric that represents the average tail
loss in a probability distribution [RU00]. It is convex in the loss variable and thus offers a
computationally suitable alternative to the dose-volume constraint. In the recent literature,
CVaR has been used to formulate linear constraints on the average dose in the upper and
lower tails of a structure’s dose distribution, leading to significant improvements in treat-
ment plans [RAD+03] [RAJFDK06] [CMP14]. However, CVaR functions are parametric,
and implementations of this model require a heuristic search over the parameter space to
obtain a good approximation of the dose-volume constraint [AGS+10].
Perhaps the method most similar to ours is [ZST+13]. In this paper, the authors propose
constraining the dose moments to equal those of the desired dose-volume histogram curve.
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They derive a convex relaxation of these constraints, then solve their treatment planning
problem in two phases: the first phase adds slack variables to the moment bounds, so a
solution is always feasible, while the second phase tightens these bounds in order to improve
upon plan quality whenever possible. Using only three moments, their technique is able to
closely match the reference histogram curves in a prostate cancer case.
These results demonstrate the power of convex models: they provide more flexibility
than linear or quadratic models, while avoiding the issue of multiple local optima in non-
convex formulations and the intractability of a mixed-integer program. In this paper, we
propose a new convex formulation of the fluence map optimization problem with dose-volume
constraints. Given a predetermined number of candidate beams, we construct a convex
optimization problem around a set of clinical goals and solve for the radiation intensity
pattern that best achieves these goals subject to restrictions on the dose distribution. Our
algorithm is quick and efficient, allowing clinicians to rapidly compare trade-offs between
different plans and select the best treatment for a patient. We provide a Python package,
ConRad, that implements our method within a simple intuitive interface.
This paper is organized as follows: In Sect. 2, we review the radiation treatment planning
problem. In Sect. 3, we describe the patient characteristics and constraints that clinicians
must consider when selecting an optimal plan. In Sect. 4, we define a convex optimization
framework for the basic treatment planning problem. Sect. 5 introduces dose constraints.
We show how to incorporate dose-volume constraints via a convex restriction, which provides
an approximation of the dose percentile. In Sect. 6, we present two extensions to our model.
Sect. 7 describes the Python implementation of our algorithm, and Sect. 8 demonstrates its
performance in several clinical cases. Finally, Sect. 9 concludes.
2 Problem Description
During external beam radiation therapy, ionizing radiation travels through a patient, de-
positing energy along the beam paths. Radiation damages both diseased and healthy tissue,
but clinicians aim to damage these tissues differentially, exploiting the fact that cancer cells
typically have faulty cell repair mechanisms and exhibit a lower tolerance to radiation than
healthy cells. The goal is to focus radiation beams such that enough dose is delivered to
kill diseased tissue, while avoiding as much of the surrounding healthy organs as possible.
The clinician separates these structures into one or more planning target volumes (PTVs)
to be irradiated at a prescribed dose level and several organs-at-risk (OARs) to spare from
radiation.
Before treatment, the patient is positioned on a couch. Photon, electron, proton, or
heavier particle beams are generated with a particle accelerator and coupled to a mechanized
gantry that contains additional hardware components, which shape and focus the beams.
The gantry typically rotates around one central axis (but may have additional rotational and
translational degrees of freedom [MHS+93] [GHBF+13] [JCM+98]), so that by controlling
the gantry and couch, beams can be delivered from almost any angle and location around
the patient.
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Delivery strategies vary from using a large number of apertures (beam shapes) delivered
sequentially from a few beam angles, as in intensity-modulated radiation therapy (IMRT), to
calculating a single optimal aperture at a large number of angles, as in volumetric modulated
arc therapy (VMAT). For a given delivery strategy, the goal of treatment planning is to
determine the optimal beam angles, shapes and intensities that most closely approximate
a desired dose distribution to the targeted volumes. In this work, we consider the task of
optimizing intensities for a given set of beams of known positions and shapes, i.e., calculating
optimal beam weights. This is applicable to the fluence map optimization (FMO) step in
IMRT planning, the FMO step in direct aperture optimization for modalities such as VMAT,
4pi, or SPORT [Bed09] [DLR+13] [LX13], as well as inverse planning problems for other
common modalities such as stereotactic radiosurgery [SFOM00] [SSJRA06] or proton beam
therapy [OB01].
3 Clinical Planning
3.1 Dose Physics
Prior to treatment, medical images—such as CT, MRI and PET scans—are collected to
form a three-dimensional image of the patient’s anatomy. This representation is discretized
into regular volume elements, or voxels. The anatomy is then delineated by clinicians into
various structures, and the dose to each structure is considered during planning. Although
the structure contours drawn by clinicians may overlap, in this work, we associate each voxel
with a single structure.
Dose calculation algorithms range from analytical approximations to Monte Carlo simu-
lations, but in all cases, they provide a model with a linear mapping from beam intensities
to delivered voxel doses. The dose within each voxel is assumed to be uniform. For each
candidate beam, we have an aperture shape that may be further subdivided, e.g., into reg-
ular rectangular subdivisions called beamlets. The intensities of these beams (or beamlets)
are represented in a vector. A patient-specific dose deposition matrix maps this vector of
radiation intensities to the vector of doses delivered per voxel.
3.2 Dose Objectives
Given a fixed number of candidate beams, our goal is to determine the beam intensities that
satisfy a clinical objective defined in terms of the dose delivered to each voxel in the patient
anatomy.
Every PTV is prescribed a desired dose, which we wish to deposit uniformly throughout
the target. Delivering too high or too low a dose of radiation has different clinical conse-
quences, so we introduce separate underdose and overdose penalties for every PTV. In the
case of OARs, a lower dose is always preferable, so we penalize any dose above zero and omit
an underdose penalty term. In addition to clinical considerations, such as the patient’s med-
ical history and past courses of radiation therapy, different organs usually exhibit different
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levels of sensitivity to radiation. For these reasons, we allow the penalties for each OAR to
be scaled independently, allowing the planner to adjust the relative importance of meeting
the dose targets for each structure separately.
We apply the penalty associated with each structure to every voxel in that structure, and
the objective function of our treatment planning problem tallies these dose penalties over all
voxels in a patient’s anatomy.
3.3 Dose Constraints
In addition to dose penalties, we allow for hard constraints on the amount of radiation
delivered to portions of the patient anatomy. For example, the clinician may only consider
plans in which the spinal column receives a dose below a certain level because any more
will increase the likelihood of injury beyond an acceptable limit. Basic constraints of this
nature take the form of bounds on the mean, minimum, and maximum dose to a structure.
More generally, bounds can be enforced on the dose to a fraction of the voxels in a structure.
These dose-volume constraints restrict the relative volume that receives radiation beyond a
particular threshold, giving the clinician precise control over the dose distribution. This is
especially important when sparing OARs, since some organs are able to sustain high levels of
uniform radiation, while others will fail unless the radiation is contained to a small fraction
of the tissue.
Clinicians typically use a dose-volume histogram (DVH) to assess the quality of a treat-
ment plan. For every structure, the DVH specifies the percentage of its volume that receives
at least a certain dose. A point (x, y) on the curve indicates that y% of the total voxels
in the structure receives a dose of at least x Gy. Ideally, we want our structures to receive
exactly the prescribed dose throughout their volumes. If the prescription is d Gy, then our
optimal DVH curve for the PTV is a step function with a drop at (d, 100), and our optimal
DVH for each OAR exhibits a drop at (0, 100).
Dose constraints restrict the shape and location of points on the DVH curve. In Fig. 1, a
lower dose-volume constraint, D(90) ≥ 60, is represented by the right-facing arrow centered
at (60, 90). This ensures that a minimum of 90% of the structure’s volume receives at least 60
Gy, i.e., y ≥ 90 along the vertical line x = 60. The PTV’s DVH curve is pushed rightward
by this type of constraint. Similarly, an upper dose-volume constraint, D(33) ≤ 12, is
labeled with a left-facing arrow at (12, 33), which pushes the OAR’s DVH curve leftward,
representing the restriction that y ≤ 33 along the line x = 12. Together, the DVH curves
and their respective dose constraints enable the clinician to easily visualize trade-offs when
formulating a treatment plan.
4 Convex Formulation
Consider a case with m voxels inside a patient volume and n candidate treatment beams.
Our goal is to determine the beam intensities x ∈ Rn+ that deliver a vector of voxel doses
y ∈ Rm+ , which meet a set of clinical objectives. We are given a case-specific dose influence
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Figure 1: (a) A lower DVH constraint ensures at least 90% of the structure’s volume
receives at least 60 Gy. The dotted line intersects the curve at (60, 90). (b) An upper DVH
constraint allows at most 33% of the volume to receive at least 12 Gy.
matrix A ∈ Rm×n+ that approximates the relationship between the beams and doses linearly
as y = Ax. We refer to the rows of A as ai ∈ Rn+ for i = 1, . . . ,m. The basic inverse
treatment planning problem is of the form
minimize f(y)
subject to y = Ax
x  0
with respect to x and y, where f : Rm → R is a convex loss function chosen to penalize
voxel doses based on the goals of the clinician. Here, the inequality on x is understood to
be applied element-wise. In a typical case, a patient is prescribed a treatment plan that can
be characterized by a vector of doses d ∈ Rm+ to each voxel. Our function f then penalizes
the deviation of the calculated dose y from the prescribed dose d, taking into account the
different structures inside a patient.
In our formulation, we consider a loss function f(y) =
∑m
i=1 fi(yi) where yi = a
T
i x and
each fi is a piecewise-linear function
fi(yi) = w
−
i (yi − di)− + w+i (yi − di)+.
The parameters w−i and w
+
i are the non-negative weights on the underdose and overdose, re-
spectively. This penalty structure is common in the literature [LC12] [CUT+12] and provided
the most efficient software implementation.
Prior to treatment planning, the m voxels in a patient volume are grouped into S distinct,
non-overlapping sets representing the planning target volume (PTV), organs-at-risk (OARs),
and generic non-target tissue (often labeled “body”). Each set Vs contains all the voxel
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indices i within a corresponding internal structure with index s. Together, {Vs}S1 forms a
partition of the patient volume, i.e.,
⋃S
1 Vs covers all voxel indices and Vs1
⋂Vs2 = ∅ for
s1 6= s2. We assume the indices are ordered such that s = 1, . . . , P ≤ S are targets and the
rest non-targets.
For simplicity, we choose our voxel doses and penalties to be uniform within each struc-
ture. We let ds represent the prescribed dose, and w
−
s and w
+
s the underdose and overdose
penalties for all voxels i ∈ Vs. The loss function for our basic inverse planning problem is
f(y) =
∑S
s=1 fs(yi) where
fs(yi) =
∑
i∈Vs
fi(yi) =
∑
i∈Vs
{w−s (yi − ds)− + w+s (yi − ds)+}.
A non-target structure s is always prescribed a dose of zero, and since y ≥ 0, its individual
loss simplifies to fi(yi) = w
+
s yi. Thus, its only contribution to the objective is through its
total dose. An example of these loss functions is given in Fig. 2. We can collapse the sum
of non-target losses into a single linear term,
S∑
s=P+1
fs(yi) =
S∑
s=P+1
w+s
(∑
i∈Vs
yi
)
=
S∑
s=P+1
w+s zs = c
T z,
where c = (w+P+1, . . . , w
+
S ) and z =
(∑
i∈VP+1 yi, . . . ,
∑
i∈VS yi
)
. Our objective is then
f(y) =
P∑
s=1
∑
i∈Vs
{w−s (yi − ds)− + w+s (yi − ds)+}+ cT z.
This formulation is closely related to quantile regression [DFV13]. In the latter, we
minimize
∑
i φ(yi − v − di) with respect to (x, v) where
φ(u) = τ(u)+ + (1− τ)(u)− = 1
2
|u|+
(
τ − 1
2
)
u
is the tilted `1 penalty with τ ∈ (0, 1). For our inverse planning problem, the residual
ri := yi − v − di can be interpreted as the difference between calculated and desired doses,
allowing for a uniform dose offset v ∈ R within each structure. We rewrite our individual
loss as
fi(yi − v) = w−i (ri)− + w+i (ri)+
= (w−i + w
+
i )
(
w−i
w−i +w
+
i
(ri)− +
w+i
w−i +w
+
i
(ri)+
)
= (w−i + w
+
i )
(
1
2
|ri|+
(
w+i
w−i +w
+
i
− 1
2
)
ri
)
,
and the loss function becomes
fs(yi − v) =
∑
i∈Vs
fi(yi − v) = (w−s + w+s )
∑
i∈Vs
(
1
2
|ri|+
(
τs − 1
2
)
ri
)
,
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Figure 2: (a) The loss function for a PTV prescribed ds = 1 with penalties w
−
s = 1 and
w+s = 2, and (b) the loss function for an OAR with penalty w
+
s′ = 1.6.
where τs :=
w+s
w−s +w+s
∈ (0, 1). For ri 6= 0, the first order condition with respect to v is
∂fs(yi − v)
∂v
= τs|{i : ri > 0}| − (1− τs)|{i : ri < 0}| = 0,
which implies τs|Vs| = |{i : ri < 0}|, i.e., in a given structure s, the τs-quantile of optimal
residuals is zero. Although our original loss does not include v, we can use this as a rule of
thumb for selecting relative dose penalties (w−s , w
+
s ).
5 Dose Constraints
5.1 Percentile
A percentile constraint, otherwise known as a dose-volume constraint, bounds the dose deliv-
ered to a given percentile of a patient structure. This allows us to set a limit on the fraction
of total voxels that are under- or overdosed with respect to a user-provided threshold. For
clinicians, this provides a way to shape the dose-volume histogram directly rather than by
searching through combinations of objective weights to achieve desired dose statistics. Given
a structure s and dose vector y, let Ds(p, y) represent the minimum dose delivered to p per-
cent of all voxels in s, i.e., Ds(p, y) is the greatest lower bound on the dose received by p%
of the tissue.
To formalize this notion, we define an exact value count function vs : R
m
+ ×R+ → Z+,
which computes the total number of voxels i ∈ Vs that receive a dose above b ∈ R+. Let
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g(u) = 1{u ≥ 0}, then
vs(y, b) =
∑
i∈Vs
1{yi ≥ b} =
∑
i∈Vs
g(yi − b)
and our p-th percentile dose is
Ds(p, y) = max{b ∈ R+ : vs(y, b) ≥ φs(p)} where φs(p) := p
100
|Vs|.
Observe that Ds(p, y) ≥ 0 is finite and weakly decreasing in p.
Our goal is to bound Ds(p, y). For example, we may want at least 30% of the voxels in
structure s to receive a dose above 25 Gy; this is identical to Ds(30, y) ≥ 25. Let ` < u
be non-negative scalar values. An lower dose-volume constraint, Ds(p, y) ≥ `, requires the
number of voxels in s that receive a dose above ` to be at least p% of the total voxels in the
structure. Similarly, an upper dose-volume constraint, Ds(p, y) ≤ u, requires the number of
voxels i ∈ Vs with a dose above u to be at most p% of voxels in Vs, or equivalently, at least
100− p% of the voxels to receive a dose under u. Thus, the inequalities
Ds(p, y) ≤ u ⇔ vs(y, u) ≤ φs(p) ⇔ vs(−y,−u) ≥ φs(100− p)
are equivalent, as are
Ds(p, y) ≥ ` ⇔ vs(y, `) ≥ φs(p) ⇔ vs(−y,−`) ≤ φs(100− p).
In general, this is a hard combinatorial problem: the brute force approach for a single
upper dose-volume constraint, for example, is to solve all
(|Vs|
φ
)
convex problems obtained
by choosing subsets of φ = dφs(p)e voxels to constrain below u, which is prohibitively large
given the size of patient geometries.
5.2 Mean, Minimum, and Maximum
In a few special cases, we can set convex constraints on the dose. Let the average, minimum,
and maximum dose delivered to all voxels in structure s be
Davgs (y) =
1
|Vs|
∑
i∈Vs
yi, D
min
s (y) = min
i∈Vs
{yi}, Dmaxs (y) = max
i∈Vs
{yi}.
A lower bound b ∈ R+ on the minimum dose is equivalent to requiring yi ≥ b for all
i ∈ Vs, and similarly for an upper bound on the maximum dose. Thus, we can enforce linear
constraints on these dose statistics in our problem. Our non-convex formulation with exact
dose-volume constraints is
minimize f(y)
subject to y = Ax
x  0
`s,k ≤ Ds(ps,k, y) ≤ us,k, k = 1, . . . , Ks, s = 1, . . . , S
`avgs ≤ Davgs (y) ≤ uavgs , s = 1, . . . , S
Dmins (y) ≥ `mins , s = 1, . . . , S
Dmaxs (y) ≤ umaxs , s = 1, . . . , S,
(1)
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where (x, y) are our variables, and for each structure s, we index the parameters of its
dose-volume constraints with k = 1, . . . , Ks.
5.3 Convex Restriction
To address the non-convexities in Prob. 1, we introduce a convex restriction that provides
an effective heuristic for satisfying the dose-volume constraints. Our restricted constraint
overestimates the number of voxels that are underdosed with respect to d by replacing the
indicator g in v with a family of hinge loss functions
gˆλ(u) = (1 + λu)+ = max(1 + λu, 0),
parametrized by λ > 0, giving us a restricted value count for structure s of
vˆs(y, b;λ) =
∑
i∈Vs
gˆλ(yi − b) =
∑
i∈Vs
(1 + λ(yi − b))+.
If u > 0, then g(u) = 1 < 1 + λu = gˆλ(u), and if u ≤ 0, then g(u) = 0 ≤ gˆλ(u). Hence,
g(u) ≤ gˆλ(u) for all u ∈ R and λ > 0 (Fig. 3). Evaluating at ui = yi − b and summing over
all voxels i ∈ Vs, we obtain
vs(y, b) =
∑
i∈Vs
g(yi − b) ≤
∑
i∈Vs
gˆλ(yi − b) = vˆs(y, b;λ).
An upper bound on the restricted value count at a given point thus ensures the exact value
count is bounded above as well.
We can guarantee our dose-volume constraints hold by enforcing specific limits on vˆ. If
vˆs(y, u;λ) ≤ φs(p), then vs(y, u) ≤ φs(p), and the upper dose-volume constraint, Ds(p, y) ≤
u, is satisfied. Similarly, vˆs(−y,−`;λ) ≤ φs(100− p) implies that Ds(p, y) ≤ `. To simplify
notation, we rewrite vˆs(y, b;λ) ≤ φ as∑
i∈Vs
(1 + λ(yi − b))+ ≤ φ.
Since λ > 0, we can divide both sides of the inequality by λ. Letting α := 1
λ
and gathering
all terms on the left-hand side, we obtain the inequality∑
i∈Vs
(α + (yi − b))+ − αφ ≤ 0.
The left-hand side of this inequality is a sum of convex functions of (α, y), and hence convex.
Note that while λ was a parameter of our restricted value count function, α > 0 can be an
optimization variable, since the left-hand term is jointly convex in α and y. Additionally, we
can replace the constraint α > 0 with α ≥ 0 because when α = 0, the constraint simplifies
10
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Figure 3: The indicator function g(u) (solid) and hinge loss gˆλ(u) with λ = 2 (dashed).
Note that gˆλ(u) ≥ g(u) for all u ∈ R, so the hinge loss provides a convex restriction on the
dose-volume constraint.
to (yi − b)+ ≤ 0, which is equivalent to yi ≤ b for all i ∈ Vs. Certainly in this case, the
condition Ds(p, y) ≤ b holds. Thus, by defining the functions
Dˆ+s (p, y, b, α) =
∑
i∈Vs
(α + (yi − b))+ − αφs(p)
for upper constraints and
Dˆ−s (p, y, b, α) =
∑
i∈Vs
(α− (yi − b))+ − αφs(100− p),
for lower constraints, each convex restriction can be represented by inequalities in terms of
these functions: for α ≥ 0, Dˆ+s (p, y, u, α) ≤ 0 implies Ds(p, y) ≤ u, and Dˆ−s (p, y, `, α) ≤ 0
implies Ds(p, y) ≥ `. Our convex formulation with restricted dose-volume constraints is
minimize f(y)
subject to y = Ax
x  0, α  0
Dˆ+s
(
ps,k, y, us,k, α
(u)
s,k
)
≤ 0, k = 1, . . . , K(u)s , s = 1, . . . , S
Dˆ−s
(
ps,k, y, `s,k, α
(`)
s,k
)
≤ 0, k = 1, . . . , K(`)s , s = 1, . . . , S
`avgs ≤ Davgs (y) ≤ uavgs , s = 1, . . . , S
Dmins (y) ≥ `mins , s = 1, . . . , S
Dmaxs (y) ≤ umaxs , s = 1, . . . , S,
(2)
where for every structure s, we index the parameters of its upper dose-volume constraints
with k = 1, . . . , K
(u)
s , and its lower dose-volume constraints with k = 1, . . . , K
(`)
s . We
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include a separate optimization variable, αs,k, in each dose-volume constraint to represent
the inverse slope of its convex restriction and stack these variables in a vector α := (α(`), α(u)).
Optimizing over α in addition to (x, y) ensures we obtain the best hinge loss approximation
to the value count function. The above formulation is a restriction of our original problem:
if (x, y, α) is feasible for Prob. 2, then (x, y) is feasible for Prob. 1.
6 Refinements
6.1 Two-Pass Refinement
A solution (x∗, y∗, α∗) to Prob. 2 satisfies our restricted dose-volume constraints, so it is
feasible for our original Prob. 1 with exact dose-volume constraints. However, since the
convex restriction enforces an upper bound on the restricted value count function vˆ, the
feasible set of Prob. 2 is a subset of the feasible set of Prob. 1, and (x∗, y∗) may not be optimal
for the latter. One way to improve our solution is to bound only the minimum number of
voxels in each structure required to satisfy the dose-volume constraint. A good heuristic
is to select those voxels i that receive a dose y∗i , which satisfies the associated dose-volume
bound by the largest margin, and re-solve the problem with the convex restriction replaced
by bounds on just these voxels. The solution of this second pass, (x∗∗, y∗∗), will achieve an
objective value f(y∗∗) ≤ f(y∗) while still satisfying our exact dose-volume constraints.
To make this precise, consider the lower dose-volume constraint Ds(p, y) ≥ `. This is
equivalent to yi ≥ ` for at least φs(p) voxels in structure s. Given y∗ from our first pass
optimization, we compute the margin ξ∗i = (y
∗
i − `) and select the qs = dφs(p)e voxels i ∈ Vs
with the largest values of ξ∗i . Call this subset Q−s ⊆ Vs. Now, we replace Ds(p, y) ≥ ` in
Prob. 1 with the precise voxel constraints yi ≥ ` for all i ∈ Q−s . On the second pass,
vs(y, `) =
∑
i∈Vs
1{yi ≥ `} ≥
∑
i∈Q−s
1{yi ≥ `} = qs ≥ φs(p),
so our upper dose-volume constraint is satisfied. An analogous argument with qs = dφs(100−
p)e and ξ∗i = (u−y∗i ) produces the subset Q+s for an upper dose-volume constraint Ds(p, y) ≤
u. Given a solution (x∗, y∗, α∗) to Prob. 2, we repeat this process with every such constraint
to obtain the second-pass problem formulation
minimize f(y)
subject to y = Ax
x  0
yi ≤ us,k ∀i ∈ Q+s,k, k = 1, . . . , K(u)s , s = 1, . . . , S
yi ≥ `s,k ∀i ∈ Q−s,k, k = 1, . . . , K(`)s , s = 1, . . . , S
`avgs ≤ Davgs (y) ≤ uavgs , s = 1, . . . , S
Dmins (y) ≥ `mins , s = 1, . . . , S
Dmaxs (y) ≤ umaxs , s = 1, . . . , S,
(3)
12
where the voxel subsets are indexed with k = 1, . . . , K
(u)
s for upper dose-volume constraints,
and k = 1 . . . , K
(`)
s for lower dose-volume constraints. We can warm start our solver at
(x∗, y∗) to speed up the second pass optimization.
Algorithm 6.1 Two-pass algorithm.
given a dose matrix A ∈ Rm×n, a prescribed dose vector d ∈ Rm,
and a set of dose-volume constraints C.
1. First pass. Obtain the solution (x∗, y∗, α∗) to Prob. 2.
for each (`, p, s) ∈ C do
2a. Compute margins. Calculate ξ∗i = y
∗
i − ` for all i ∈ Vs.
2b. Sort margins. Sort {ξ∗i }i∈Vs in ascending order to form a set ξs.
2c. Identify voxel subset. Select the dφs(p)e largest values ξi ∈ ξs
and include their indices i in Q−s,k.
end for
for each (u, p, s) ∈ C do
3a. Compute margins. Calculate ξ∗i = u− y∗i for all i ∈ Vs.
3b. Sort margins. Sort {ξ∗i }i∈Vs in ascending order to form a set ξs.
3c. Identify voxel subset. Select the dφs(100− p)e largest values ξi ∈ ξs
and include their indices i in Q+s,k.
end for
4. Second pass. Obtain the solution (x∗∗, y∗∗) to Prob. 3 using (x∗, y∗) as a warm start point.
6.2 Dose Constraints with Slack
If our dose constraints are too strict, Prob. 2 may not have a solution. This can arise even
if the feasible set for our original Prob. 1 is non-empty, since our convex restriction enforces
more stringent bounds on the dose distribution. To ensure the first pass of our algorithm
always supplies a solution, we introduce a slack variable δ ∈ R+ to the bounds of each dose
constraint, mapping lower bounds ` 7→ (`− δ) and upper bounds u 7→ (u+ δ). This creates
soft constraints that need not be met precisely by the solution. Our problem reformulated
with restricted dose-volume constraints and slack is
minimize f(y)
subject to y = Ax
x  0, α  0, δ  0
Dˆ+s
(
ps,k, y, us,k + δ
(u)
s,k , α
(u)
s,k
)
≤ 0, k = 1, . . . , K(u)s , s = 1, . . . , S
Dˆ−s
(
ps,k, y, `s,k − δ(`)s,k, α(`)s,k
)
≤ 0, k = 1, . . . , K(`)s , s = 1, . . . , S
`avgs − δavg,(`)s ≤ Davgs (y) ≤ uavgs + δavg,(u)s , s = 1, . . . , S
Dmins (y) ≥ `mins − δmins , s = 1, . . . , S
Dmaxs (y) ≤ umaxs + δmaxs , s = 1, . . . , S,
(4)
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Note that δ := (δ(u), δ(`)) is a variable in the optimization, and the value of each δs,k indicates
the amount (in units of delivered dose, e.g., Gy) by which each bound is weakened in the
solution.
We can incorporate soft constraints into the two-pass algorithm as well. On the first
pass, we solve Prob. 4 to obtain the optimal variables (x∗, y∗, α∗) and the optimal slacks
δ∗. Our margin for selecting Qs is now computed with respect to the slack bound, i.e.,
ξ∗i = (y
∗
i − ` + δ∗) for lower-volume dose constraints, and ξ∗i = (u + δ∗ − y∗i ) for upper
dose-volume constraints. Finally, we weaken the bounds in Prob. 3 by δ∗, giving us the
reformulated second pass optimization with slack dose-volume constraints
minimize f(y)
subject to y = Ax
x  0
yi ≤ us,k + δ(u)∗s,k ∀i ∈ Q+s,k, k = 1, . . . , K(u)s , s = 1, . . . , S
yi ≥ `s,k − δ(`)∗s,k ∀i ∈ Q−s,k, k = 1, . . . , K(`)s , s = 1, . . . , S
`avgs − δavg,(`)∗s ≤ Davgs (y) ≤ uavgs + δavg,(u)∗s , s = 1, . . . , S
Dmins (y) ≥ `mins − δmin ∗s , s = 1, . . . , S
Dmaxs (y) ≤ umaxs + δmax ∗s , s = 1, . . . , S.
(5)
Algorithm 6.2 Two-pass algorithm with slack.
given a dose matrix A ∈ Rm×n, a prescribed dose vector d ∈ Rm,
and a set of dose-volume constraints C.
1. First pass. Obtain the solution (x∗, y∗, α∗, δ∗) to Prob. 4.
for each (δ∗, `, p, s) ∈ C do
2a. Compute margins. Calculate ξ∗i = y
∗
i − `+ δ∗ for all i ∈ Vs.
2b. Sort margins. Sort {ξ∗i }i∈Vs in ascending order to form a set ξs.
2c. Identify voxel subset. Select the dφs(p)e largest values ξi ∈ ξs
and include their indices i in Q−s,k.
end for
for each (δ∗, u, p, s) ∈ C do
3a. Compute margins. Calculate ξ∗i = u+ δ
∗ − y∗i for all i ∈ Vs.
3b. Sort margins. Sort {ξ∗i }i∈Vs in ascending order to form a set ξs.
3c. Identify voxel subset. Select the dφs(100− p)e largest values ξi ∈ ξs
and include their indices i in Q+s,k.
end for
4. Second pass. Obtain the solution (x∗∗, y∗∗) to Prob. 5 using (x∗, y∗) as a warm start point.
7 Implementation
We implement our radiation treatment planning methodology with ConRad, a Python-embedded
open-source software package based on the convex programming library, CVXPY [DB16],
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using the convex solvers SCS [OCPB16] and ECOS [DCB13]. ConRad provides a simple,
intuitive interface for ingesting patient data, constructing plans based on a clinical prescrip-
tion, and visualizing the dose-volume histograms of the result. It allows the user to add dose
constraints using syntax familiar to clinicians. Since ConRad is an ordinary Python library,
it can be easily integrated into existing data processing pipelines.
The following code imports a prescription, solves for the optimal treatment plan with-
out dose constraints, and plots the DVH curves for all the patient structures. The m × n
dose-influence matrix A can be encoded as a NumPy ndarray or any of several sparse rep-
resentations in Python. The m-length vector voxel labels enumerates the index of the
assigned structure for each voxel in the patient volume.
import conrad
# Construct the case with no dose constraints
case = conrad.Case()
case.prescription = "/Documents/prescriptions/rx_patient_01.yaml"
case.physics.dose_matrix = A
case.physics.voxel_labels = voxel_labels
graphics = conrad.CasePlotter(case)
# Solve with a single pass and no slack
status, run = case.plan(solver="ECOS", use_slack=False, use_2pass=False)
print("Problem feasible?:\n{}".format(status))
print("Dose summary:\n{}".format(case.dose_summary_string))
# Display color-coded plot of all DVH curves
graphics.plot(run, show=True)
A Case object comprises Anatomy, Physics, Prescription and PlanningProblem ob-
jects. Prior to planning, the case’s Anatomy and Physics objects must be built. The user
can either build the case’s Anatomy by adding structures programmatically (with data on
each structure’s name, index, identity as target/non-target, and desired dose) or by ingesting
a prescription, which can be supplied as a Python dictionary or as a YAML or JSON file for-
matted for ConRad’s parser. The minimum information required for the case’s Physics object
are the m× n dose matrix and a m-length vector of voxel labels. The case’s Prescription
object can be used to populate the Anatomy object or to keep track of clinical guidelines and
objectives. It can also be left empty.
The case’s PlanningProblem object builds and solves optimization problems based on
the structures in the case anatomy and any constraints assigned to those structures. The
PlanningProblem is not exposed to the user. Instead, users form a treatment plan by calling
the case’s plan() method, which returns a bool status indicating whether the specified
problem was feasible, along with a RunRecord object that carries solver performance data,
optimal variables, and DVH curves.
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Before planning a case, the user can add, remove, or modify dose constraints to any
structure. Thus, even when a case has an assigned prescription, the dose constraints at-
tached to each structure in the case anatomy may differ from the constraints specified in the
prescription. For example, the prescribed constraints may correspond to clinical guidelines,
while the constraints used during planning may be chosen arbitrarily by the user to obtain
plans with desirable dose properties.
After planning a case, users can plot the DVH curves, retrieve and print summaries
of dose statistics for each structure, and when applicable, display a report of whether the
current plan satisfies each constraint listed in the prescription. A case can be re-planned
with different objective weights or dose constraints on any structure. The ConRad library
provides a PlanningHistory object to retain and manage results from prior runs.
The following code adds a dose-volume constraint to the PTV from our previous case,
allowing at most 20% of the PTV’s voxels to receive more than 70 Gy. Algorithm 6.1 is then
applied to obtain an optimal beam output.
# Constraint allows at most 20% of PTV voxels to receive dose above 70 Gy
case.anatomy["PTV"].constraints += D(20) <= 70 * Gy
# Solve with two-pass algorithm and no slack
_, run = case.plan(solver="ECOS", use_slack=False, use_2pass=True)
print("x PASS 1: {}".format(run.x_pass1))
print("x PASS 2: {}".format(run.x_pass2))
# Plot DVH curves from first (dashed) and second pass (solid)
graphics.plot(run, show=False, ls="--")
graphics.plot(run, second_pass=True, show=True, clear=False, legend=True)
8 Examples
8.1 Basic Functionality
We present results illustrating the methods described in this paper: approximating dose-
volume constraints via convex restrictions, two-pass refinement of plans with dose-volume
constraints, and handling incompatible constraints with slack variables.
Problem Instances. We demonstrate the basic functionality on a head-and-neck case
expressed as a VMAT aperture re-weighting problem. The case contains 360 apertures in
four arcs, 270,000 voxels distributed across 17 planning structures, including the PTV treated
to 66 Gy, two auxiliary targets treated to 60 Gy, several OARs, and generic body voxels.
To test the handling of dose-volume constraints, we plan the case with no dose constraints
and then re-plan with a single dose-volume constraint applied to the PTV, namely D(20) ≤
70 Gy. We run the two-pass algorithm and compare the plans obtained by applying restricted
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and exact versions of the aforementioned dose-volume constraint. Finally, we test the slack
method by planning the case with two incompatible dose-volume constraints: D(98) ≥ 66
Gy on the PTV and D(20) ≤ 20 Gy on the spinal cord. We compare the results from
enforcing the PTV constraint alone, both constraints without slack, and both constraints
with slack allowed.
Computational Details. The size of the dose matrix passed from ConRad to the convex
solvers in the backend varied depending on the dose constraints. When no minimum, maxi-
mum, or dose-volume constraints were applied to a non-target structure, the submatrix for
that structure was replaced with a mean dose representation, thereby eliminating |Vs| − 1
rows from the problem matrix. In particular, the matrix representing the full dose on the
targets and mean dose for non-targets had dimensions 11,141 × 360, and the matrix includ-
ing the full dose on the spinal cord was 15,000 × 360. The ConRad problem request was
formulated as a convex program in CVXPY and passed to a GPU-based implementation
of the convex solver SCS. Calculations were performed on a cluster with 32-core, 2.20 GHz
Intel Xeon E5-4620 CPU and a nVidia TitanX graphics card.
Clinical Results: Dose-Volume Constraints. Fig. 4a depicts the DVH curves of the
plan produced without any dose constraints. The PTV curve is shown in red with a dotted
vertical line marking its prescribed dose of 66 Gy. The rest are DVHs for the OARs and
generic body voxels. This solution to the unconstrained problem already gives a fairly good
treatment plan. The DVH of the right cochlea and left parotid are pushed far left, so only
15–20% of their volume exceed 10 Gy, and almost no voxels are dosed above 30 Gy. The
spinal cord receives somewhat more radiation, while the worst case is the brain with a slow,
nearly linear drop-off to about 75 Gy.
The PTV curve begins to fall at 66 Gy, but does not reach zero until nearly 95 Gy. To
reduce this overdosing, we add a dose-volume constraint that limits no more than 20% of
the PTV to receive over 70 Gy, as indicated by the red, left-pointing arrow in Fig. 4b, and
re-plan the case. The resulting DVH curves are depicted as solid lines in Fig. 4c, while the
dashed curves represent the original plan. Under the new plan, the PTV curve has been
pushed left at the arrow, and its drop-off around 66 Gy is steeper, meaning all voxel doses
are closer to the prescription. Moreover, our OARs are minimally affected. We have reduced
overdosing to the PTV without significantly increasing radiation to other organs.
Clinical Results: Two-Pass Algorithm. A close inspection of Fig. 4c reveals a gap
between the PTV curve and the DVH constraint arrow. This is due to the conservative
nature of the convex restriction, which overestimates the number of voxel violations. We
can eliminate this gap and improve our overall objective with the two-pass algorithm. Fig.
5a shows the plan from the first pass. There is a margin of about 0.5 Gy between the PTV
curve and arrow, meaning at most 20% of the PTV receives over 69.5 Gy, a more restrictive
solution than required by our constraint D(20) ≤ 70 Gy.
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Figure 4: DVH curves for PTV and several OARs from the 4-arc VMAT head-and-neck
case. (a) Plan without any dose constraints. (b) Add a dose-volume constraint D(20) ≤ 70
Gy. (c) Re-plan with the new constraint. The unconstrained plan is shown in dashed lines.
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(a) First Pass
0 20 40 60 80 100
0
20
40
60
80
100
(b) Second Pass
0 20 40 60 80 100
0
20
40
60
80
100 PTV 66Gy
Cord
Brain
Cochlea R
Parotid L
Body
Figure 5: DVH curves for a two-pass algorithm with a single dose-volume constraint on
the PTV. (a) On the first pass, the constraint is met with a margin of about 0.5 Gy. (b)
On the second pass, the constraint is met tightly with small gains elsewhere.
This margin disappears in Fig. 5b. Here, the dashed lines depict the first pass solution,
and the solid lines come from the second pass. The second pass PTV curve falls precisely on
the center of the left-facing arrow, meaning the dose-volume constraint is tight. In addition,
the DVH curves for the right cochlea and left parotid have shifted leftward, indicating they
now receive less radiation. By replacing our convex restriction with exact voxel constraints,
we are able to make gains in our OAR clinical objectives while still fulfilling the DVH
constraint.
Clinical Results: Constraints with Slack. So far, we have specified only one dose
constraint. A problem may become infeasible when multiple constraints are enforced, ei-
ther because the user-supplied bounds are too extreme or the convex restriction too severe
in its overestimation of the voxel count. In such cases, we can still produce a plan that
approximately conforms to the desired specifications by enabling slack constraints.
Fig. 6a depicts a plan created without slack. The single PTV constraint, D(98) ≥ 66
Gy, is met with margin. However, when we add the OAR constraint D(20) ≤ 20 Gy, as
symbolized by the blue arrow in Fig. 6b, and re-plan the case, the optimizer tells us that
the problem is infeasible. It is impossible to meet both (convex restricted) dose-volume
constraints exactly. We thus re-plan allowing for slack bounds on these constraints. The
resulting DVH curves are plotted in Fig. 6c with dotted lines representing the original plan
and solid lines for the new plan. The PTV constraint has been relaxed by about 3 Gy, as
symbolized by the red arrow shifting left behind the solid red curve to (98, 63). This small
concession allows us to satisfy the OAR constraint by a wide margin.
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Figure 6: DVH curves for the PTV and spinal cord. (a) Plan without slack, constraining
D(98) ≥ 66 Gy in the PTV. (b) A constraint D(20) ≤ 20 Gy is added to the spinal
cord, rendering the problem infeasible. (c) Re-plan with slack allowed. The spinal cord
constraint is met, but the PTV constraint relaxes by about 3 Gy.
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Table 1: Prostate FMO Prescription
Structure Target? Dose (Gy) Constraints (Gy)
Prostate Yes 75.6 Davg ≥ 75.6
Urethra No 0 Davg < 52.5
Bladder No 0 D(85) < 80
D(75) < 75
D(65) < 70
D(50) < 65
Rectum No 0 D(90) < 75
D(85) < 70
D(50) < 65
L. Femoral Head No 0 D(95) < 50
R. Femoral Head No 0 D(95) < 50
Body No 0 Davg < 52.5
8.2 Problem Scaling
Problem Instances. We assess the performance of our algorithm on a larger prostate
FMO problem. This case contains 74,453 voxels × 34,848 beamlets, encompassing a single
PTV treated to 75.6 Gy, five OARs with various dose constraints, and generic body voxels.
Approximately 226 million (roughly 10.6%) of the entries in the dose matrix are non-zero.
In our experiments, we used only a subset of 10,000 beamlets from this matrix.
We plan the case with the prescription detailed in Table 1, which is adapted from the
QUANTEC guidelines [MYJ+10]. The computational details are the same as in the head-
and-neck case. As before, we analyze the results from a single pass and two-pass algorithm
with and without slack allowed. We then re-plan the case with only the PTV dose constraint
and compare its runtime and OAR overdose to the plans produced from the full prescription.
Timing Results. Our algorithm produces a plan that satisfies all dose constraints using
a single pass with slack enabled. The optimization finishes in 426.9 seconds, about 2.5x the
runtime of the head-and-neck case. A second pass takes approximately the same amount of
time and does not result in significantly larger constraint margins. The presence or absence
of slack also has little impact on the runtime, which varies by at most 7 seconds.
If we drop all except the mean dose constraints, the problem collapses into a linear
program, greatly decreasing the runtime. The size of this reduction depends on the char-
acteristics of the affected structures and the dose influence matrix. For example, in the
head-and-neck case, the runtime falls by 87% to a mere 24 seconds. Conversely, when adding
dose-volume constraints, the initial constraint on a structure will have a greater impact on
runtime than subsequent additions.
21
9 Conclusion
We have developed a convex formulation for the FMO problem that incorporates dose-volume
constraints. Our model replaces each exact dose-volume constraint with a convex restriction,
which overestimates the number of voxels that violate the clinician’s desired threshold. This
allows us to solve the problem quickly and efficiently using standard convex optimization
algorithms. We also introduce two refinements: a two-pass algorithm and a model with
slack. In the former, we improve our initial solution by re-optimizing with the restrictions
replaced by bounds on a subset of voxels, enabling us to achieve a better objective that
still satisfies the dose-volume constraints. The latter allows for soft bounds and is useful if
the restricted constraints render the problem infeasible. We demonstrate the efficacy of our
method on a VMAT head-and-neck case and a prostate case. Our algorithm consistently
produces good treatment plans that fulfill all dose constraints when feasible. In problems
with infeasible constraints, we are able to generate plans that minimize the dose violation
while taking into account clinical goals, allowing clinicians to easily visualize trade-offs and
select the plan that is best for the patient.
A variety of extensions to our two-pass algorithm are possible. For instance, we could
rewrite the original problem as a mixed-integer linear program and use the solution of the
convex restriction to warm start a branch-and-bound solver. More broadly, we could apply
this starting point to accelerate any number of iterative approaches in the literature. Dose-
volume constraints are often assigned different priorities in practice, and our algorithm may
be easily adapted to accommodate such user-defined preferences, either through new penal-
ties, changes in the slack, or additional passes that impose the constraints in a lexicographic
order. These hybrid methods, which combine convex approximations with non-convex solu-
tion methods, offer an important avenue for future research.
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